During 2021, a moderate growth of 14% was observed, reaching $339 million of purchases in Central America from Mexico, where the main importer in the region was Guatemala with $83 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
By 2021, there will be a reduction in the import of pharmaceutical products containing insulin at the Central American level by 44%, equivalent to $1,948 million, with Costa Rica being the main buyer with $10 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
More than 10 thousand results were observed during May 2022 in tenders under the heading "health and medicines", ranging from medical treatments to equipment and machinery used in the health sector.
An analysis by CentralAmericaData's Business Intelligence department shows interesting data on the processes that during May 2022 were published with contracts to provide pharmaceuticals, equipment and medical supplies to the several Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
Purchases of vaccines for human use in Central America as of the third quarter of 2021 represented a value of $250 million, with Guatemalan companies being the main importers with $73 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
For the third quarter of 2021, an increase in regional imports of vaccines for veterinary use from Central America is observed with $34 million, Guatemala being the main buyer with $11 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
A cut-off for the first quarter of the year shows a relevant figure in the health and medicine sector for the Central American region and the Dominican Republic.
An analysis of CentralAmericaData's Business Intelligence department shows interesting data on the processes that in the first quarter of 2022 were published with contracts to supply pharmaceuticals, equipment and medical supplies to the various Ministries of Health and Social Security entities in Central American countries and the Dominican Republic.
In the second quarter of 2022, purchases made by Salvadoran companies increased dramatically, reaching almost 500%, representing 45% of regional purchases with $67 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
The purpose of the tender is the procurement of ocular prosthesis for the Salvadoran Social Security Institute for 12 months.
El Salvador Government Purchase LG-20220005:
"Instituto Salvadoreno del Seguro Social (ISSS) requires to contract ocular prosthesis services for Consultorio de Especialidades and Hospital Regional Sonsonate.
For the second quarter of 2021, purchases of vaccines for veterinary use remained at $23 million, the main supplier for this period was the United States with $7 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
Pharmaceutical companies need to apply location intelligence techniques and foot traffic analytics to identify consumer mobility patterns, in order to maximize sales and generate more efficient expansion models.
The correlation between foot traffic, sales, and the success of pharmacy franchises have been studied and proven, so the development of this type of analysis has become a priority in the site selection process and expansion modeling.
For the second quarter of 2021, the purchase of pharmaceutical products in the region was dominated by Costa Rica with $428 million, the largest supplier to the region was Germany with $167 million.
Figures from the Trade Intelligence Unit of CentralAmericaData: [GRAFICA caption="Click to interact with the graphic"]
With Big Data management techniques, companies can optimize their strategic business planning, by taking advantage of market and companies' data.
Big data has emerged as a powerful tool that organizations can use to leverage data-driven decision making for better strategic planning, determine which market niches of their products, are growing or shrinking, obtain traffic data of their stores or website, determining where they come from, what kind of devices they use, dwell time, and foot traffic patterns to help analyze which promotions and efforts are successfully driving their business.
Mobility analytics and location intelligence play an important role in business by helping to understand the behavioral patterns of consumers in any given zone of interest or point of sale.
Pedestrian flow analysis, location intelligence and point-of-interest categorization have revolutionized the way retail and wholesale industries implement expansion, commercial and operational strategies in the pharmaceutical sector.
The POI characterization through Big Data has become more frequent as it allows the implementation of strategies and solutions within the business sectors.
The variety of solutions based on location intelligence and zone characterization rely on efficient POI analysis, which benefits any type of business.